Market Cap: $1.06B
MC
MannKind Corporation
MNKD
NASDAQ (NASDAQ Global Market)USD
Market Cap: $1.06B
MannKind (Ticker: MNKD) grapples with significant stock price fluctuations and investor sentiment driven by its position in the biopharmaceutical sector. Recently, the company experienced a notable de…
Emerging Innovations in Cell Therapy: A Focus on α-Klotho In recent developments within the biopharmaceutical industry, Avaí Bio, Inc. has made significant strides in harnessing α-Klotho, a protein th…
MannKind Corporation: Pioneering Innovations in Diabetes Management MannKind Corporation showcases impressive advancements in diabetes management through its 2025 financial results, underscoring the c…
### MannKind Corporation's Strong Q4 Performance Signals Positive Growth in Diabetes Care MannKind Corporation's recent Q4 earnings report reveals significant advancements in its financial performance…
MannKind's Strategic Growth and Product Innovation in Diabetes Care MannKind Corporation, a notable player in the diabetes care sector, recently reported its fourth-quarter earnings, revealing a signi…
MannKind Corporation's Strategic Position in the Diabetes Treatment Market MannKind Corporation is poised to play a significant role in the diabetes management sector, particularly with its innovative…
Mannkind's Innovative Approach to Diabetes Management Mannkind Corporation is poised to make significant strides in the diabetes management sector with its innovative inhalation-based insulin therapy,…
MannKind's Strategic Focus on Market Expansion and Technology Innovation MannKind Corporation, a key player in the biopharmaceutical industry, is currently emphasizing its strategic initiatives aimed…
MannKind's Strategic Acquisition to Enhance Pharmaceutical Portfolio MannKind Corporation announces a pivotal agreement to acquire scPharmaceuticals Inc. for up to $360 million, equating to $5.35 per…
MannKind Expands Portfolio Through Strategic Acquisition of scPharmaceuticals MannKind Corporation announces its agreement to acquire scPharmaceuticals Inc. in a deal valued at up to approximately $36…
MannKind Corporation's Strategic Acquisition of scPharmaceuticals: A Leap Toward Enhanced Product Offerings MannKind Corporation (MNKD) is poised to make significant strides in the pharmaceutical sect…